medigraphic.com
Colegio de Medicina Interna de México.

2005, Number 5

<< Back Next >>

Med Int Mex 2005; 21 (5)

Nosocomial pneumonia due to Pseudomonas aeruginosa

Farías CE, Medina CRH, Chavarría GJ

Language: Spanish
References: 36
Page: 368-379
PDF size: 168.91 Kb.


ABSTRACT

Hospital-acquired pneumonia due to Pseudomonas aeruginosa is a disease that is frequently associated to high mortality. Risk factors, both from the host and the bacterium, account for its mortality and are reviewed in this paper. Early diagnosis and aggressive treatment are clues for improving the patient’s outcome measured in terms of survival.


REFERENCES

  1. Romero CR. Microbiología y parasitología humana. Bases etiológicas de las enfermedades infecciosas. 2ª ed. México: Médica Panamericana, 1999;pp:332-5.

  2. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Diagnóstico microbiológico. Texto y atlas a color. 5ª ed. Buenos Aires: Médica Panamericana, 1999.

  3. Palleroni NJ. Family I. Pseudomonadaceae. In: Krieg NR, Holt JG, editors. Bergey’s manual of systematic bacteriology. Baltimore: Williams & Wilkins, 1984.

  4. Gilardi GL. Pseudomonas and related genera. In: Balows A, editor. Manual of clinical microbiology. 5th ed. Washington: American Society for Microbiology, 1991;pp:429-41.

  5. Forkner CE. Pseudomonas aeruginosa infections. In: Wright IS, editor. Modern Medical Monographs No. 22. New York: Grune and Stratton, 1960;pp:1-5.

  6. Foca M, Jakob K, Whittier S, et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med 2000;343:695-700.

  7. Rello J, Jubert P. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 1996;23:973-8.

  8. Hall Z. Pseudomonas infection caused by bronchoscope manufacturing defects: effective national recall procedures are needed. Thorax 2003;58(4):332.

  9. Walberg M, Brantsaeter AB, Lingaas E. Outbreak of hospital-acquired monoclonal Pseudomonas aeruginosa infection associated with the use of contaminated commercial mouth swabs in a primary and tertiary care hospital in Norway. Clin Mic Inf 2003;Suppl 9(Suppl 1):367-8.

  10. Becks VE, Lorenzoni NM. Pseudomonas aeruginosa outbreak in a neonatal intensive care unit: a possible link to contaminated hand lotion. Am J Infect Control 1995;23:396-8.

  11. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999;27:887-93.

  12. Weber DJ, Rutala WA, Mayhall CG. Nosocomial respiratory tract infections and gram-negative pneumonia. In: Fishman AP, editor. Fishman’s pulmonary diseases and disorders. 3rd ed. New York: McGraw-Hill, 1998;pp:2213-33.

  13. Craven DE, Steger KA. Epidemiology of nosocomial pneumonia: new perspectives on an old disease. Chest 1995;108:1S-16S.

  14. Tablan OC, Anderson LJ, Arden NH, and the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia. Infect Control Hosp Epidemiol 1994;15:587-627.

  15. Levine SA, Niederman MS. The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia. Clin Chest Med 1991;12:523-43.

  16. Weber DJ, Rutala WA. Nosocomial infections associated with respiratory therapy. In: Mayhall CG, editor. Hospital Epidemiology and Infection Control. Baltimore: Williams & Wilkins, 1996;pp:748-58.

  17. Craven DE, Steger KA. Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996. Semin Respir Infect 1996;11:32-53.

  18. George DL. Epidemiology of nosocomial pneumonia in intensive care patients. Clin Chest Med 1995;16:29-44.

  19. Doig P, Todd T. Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect Immun 1988;56:1641-6.

  20. Stratton CW. Pseudomonas aeruginosa revisited. Infect Control Hosp Epidemiol 1990;11:101-4.

  21. Quinn J. Pseudomonas aeruginosa infections in the intensive care unit. In: Clark N, Lynch J, editors. Semin Respir Crit Care Med 2003;24(1):61-68.

  22. Murray P, Kobayashi G, Pfaller M, Rosenthal K. Diagnóstico de laboratorio de las enfermedades bacterianas. Pseudomonas y bacterias no fermentadoras relacionadas. Microbiología médica. 2a ed. Madrid: Harcourt Brace, 1997.

  23. Roa J, Bermúdez M, Acero R. Enfermedades infecciosas. Neumología. Bogotá: McGraw-Hill Interamericana, 2000.

  24. Lynch J. Hospital-acquired pneumonia. Risk factors, microbiology, and treatment. Chest 2001;119(2):373S-84.

  25. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;17:791-801.

  26. Meduri GU, Johanson GW. International Consensus Conference: clinical investigation of ventilator-associated pneumonia. Chest 1992;102:551S-2.

  27. Fagon JY, Chastre J, Wolff M, et al. Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med 2000;132:621-30.

  28. De Rosa FG, Craven DE. Ventilator-associated pneumonia: current management strategies. Infect Med 2003;20(5):248-59.

  29. Rello J, Paiva JA, Baraibar J, et al. International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest 2001;120:955-70.

  30. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 1994;35:547-57.

  31. Joshi M, Bernstein J, Solomkin J, Wester BA, Kuye O. Piperacillin-tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin-tazobactam Nosocomial Pneumonia Study Group. J Antimicrob Chemother 1999;43:389-97.

  32. Mandell GL, Petri WA. Penicilinas, cefalosporinas y otros antibióticos b-lactámicos. En: Goodman y Gilman, editores. Las bases farmacológicas de la terapéutica. 9ª ed. México: McGraw-Hill Interamericana, 1997.

  33. Palmieri OJ. Enfermedades infecciosas. Chile: McGraw-Hill Interamericana, 2001.

  34. Crouch S, Wunderink RG, Jones CB, Leeper KV. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996;109:1019-29.

  35. Erwin AL, VanDevanter DR. The Pseudomonas aeruginosa genome: how do we use it to develop strategies for the treatment of patients with cystic fibrosis and Pseudomonas infections? Curr Opin Pulm Med 2002;8(6):547-51.

  36. Holder IA. Pseudomonas vaccination and immunotherapy: an overview. J Burn CareRehabil 2001;22(5):311-20.




2020     |     www.medigraphic.com